tiprankstipranks
TME Pharma N.V. (FR:ALTME)
:ALTME
France Market
ALTME
TME Pharma N.V.
RESEARCH TOOLSreports
Want to see FR:ALTME full AI Analyst Report?

TME Pharma N.V. (ALTME) Income Statement

3 Followers

TME Pharma N.V. Income Statement

Last quarter (Q4 2025), TME Pharma N.V.'s total revenue was €-27.00K, a decrease of -258.82% from the same quarter last year. In Q4, TME Pharma N.V.'s net income was €-1.18M. See TME Pharma N.V.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 0.00€ 19.00K€ 17.00K€ 0.00€ 33.00K
Gross Profit
€ -8.00K€ -78.00K€ -127.00K€ -92.00K€ -65.97K
Operating Expenses
€ 2.90M€ 5.20M€ 5.50M€ 12.00M€ 13.45M
Depreciation and Amortization
€ 8.00K€ 17.00K€ 144.00K€ 92.00K€ 66.00K
EBITDA
€ -2.90M€ -5.25M€ -5.07M€ -11.63M€ -12.88M
Operating Income
€ -2.91M€ -5.28M€ -5.62M€ -12.03M€ -13.27M
Other Income/Expenses
€ -377.00K€ -445.00K€ -1.11M€ -3.10M€ -1.19M
Pretax Income
€ -3.29M€ -5.72M€ -6.73M€ -15.13M€ -14.45M
Net Income
€ -3.29M€ -5.72M€ -6.74M€ -15.13M€ -14.45M
Per Share Metrics
Basic EPS
€ -0.03€ -0.21€ -1.34€ -12.86€ -21.90
Diluted EPS
€ -0.03€ -0.21€ -1.34€ -12.86€ -21.90
Weighted Average Shares Outstanding
 94.15M 27.35M 5.02M 1.18M 659.00K
Weighted Average Shares Outstanding (Diluted)
 94.15M 27.35M 5.02M 1.18M 659.85K
Currency in EUR

TME Pharma N.V. Earnings and Revenue History